# Biomea Fusion, Inc.: filings

BMEA · Nasdaq · CIK 1840439 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bmea.md) · [Financials](/companies/bmea/financials.md) · [Filings](/companies/bmea/filings.md) · [Insiders](/companies/bmea/insiders.md)

## Reports and events: 109 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 80, 8-K 73, 10-Q 17, 3 14, SC 13G/A 11, SC 13G 10, 424B5 8, CORRESP 8, UPLOAD 7, S-8 6, SCHEDULE 13G/A 6, 10-K 5, DEF 14A 5, ARS 4, SCHEDULE 13G 4, 144 3, EFFECT 3, SCHEDULE 13D/A 3, 4/A 2, 5 2, S-1/A 2, S-3 2, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, D 1, DEFA14A 1, DRS 1, PRE 14A 1, S-1 1, S-1MEF 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 21:35 ET | [8-K](/filings/0001193125-26-420684.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-420684 |
| 2026-09-22 | 20:01 ET | [8-K](/filings/0001193125-26-397870.md) | 8.01 Other events | 0001193125-26-397870 |
| 2026-08-05 | 20:09 ET | [10-Q](/filings/0001193125-26-335085.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335085 |
| 2026-08-05 | 20:07 ET | [8-K](/filings/0001193125-26-335073.md) | 9.01 Financial statements and exhibits | 0001193125-26-335073 |
| 2026-06-11 | 11:11 ET | [8-K](/filings/0001193125-26-266687.md) | 5.07 Shareholder vote results | 0001193125-26-266687 |
| 2026-05-11 | 21:01 ET | [10-Q](/filings/0001193125-26-217074.md) | Quarterly report, period 2026-03-31 | 0001193125-26-217074 |
| 2026-05-11 | 20:58 ET | [8-K](/filings/0001193125-26-217037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-217037 |
| 2026-04-28 | 12:30 ET | [8-K](/filings/0001193125-26-183710.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-183710 |
| 2026-04-27 | 20:08 ET | [DEF 14A](/filings/0001193125-26-182080.md) | Proxy statement, period 2026-06-10 | 0001193125-26-182080 |
| 2026-03-24 | 20:12 ET | [10-K](/filings/0001193125-26-121825.md) | Annual report, period 2025-12-31 | 0001193125-26-121825 |
| 2026-03-24 | 20:09 ET | [8-K](/filings/0001193125-26-121811.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-121811 |
| 2026-02-25 | 11:05 ET | [8-K](/filings/0001193125-26-068375.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-068375 |
| 2026-01-14 | 21:02 ET | [8-K](/filings/0001193125-26-012908.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-012908 |
| 2025-11-04 | 21:09 ET | [10-Q](/filings/0001193125-25-264679.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264679 |
| 2025-11-04 | 21:03 ET | [8-K](/filings/0001193125-25-264631.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264631 |
| 2025-10-24 | 20:10 ET | [SCHEDULE 13D/A](/filings/0000929638-25-003999.md) | Ownership report, active investor, amended | 0000929638-25-003999 |
| 2025-10-10 | 20:06 ET | [SCHEDULE 13D/A](/filings/0000929638-25-003884.md) | Ownership report, active investor, amended | 0000929638-25-003884 |
| 2025-10-07 | 21:06 ET | [8-K](/filings/0001193125-25-233614.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-233614 |
| 2025-10-06 | 20:15 ET | [8-K](/filings/0001193125-25-231903.md) | 8.01 Other events | 0001193125-25-231903 |
| 2025-08-05 | 20:10 ET | [10-Q](/filings/0000950170-25-103041.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103041 |
| 2025-08-05 | 20:06 ET | [8-K](/filings/0000950170-25-103023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103023 |
| 2025-07-24 | 11:13 ET | [8-K](/filings/0001193125-25-163815.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-163815 |
| 2025-07-22 | 21:15 ET | [SCHEDULE 13D/A](/filings/0000929638-25-002664.md) | Ownership report, active investor, amended | 0000929638-25-002664 |
| 2025-06-20 | 21:13 ET | [8-K](/filings/0001193125-25-143747.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-143747 |
| 2025-06-18 | 21:30 ET | [8-K](/filings/0001193125-25-142830.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-142830 |
| 2025-06-17 | 20:53 ET | [8-K](/filings/0001193125-25-142126.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-142126 |
| 2025-06-13 | 20:01 ET | [8-K](/filings/0001193125-25-140718.md) | 5.07 Shareholder vote results | 0001193125-25-140718 |
| 2025-05-05 | 20:10 ET | [10-Q](/filings/0000950170-25-063543.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063543 |
| 2025-05-05 | 20:05 ET | [8-K](/filings/0000950170-25-063523.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063523 |
| 2025-04-28 | 20:05 ET | [DEF 14A](/filings/0001193125-25-100455.md) | Proxy statement, period 2025-06-11 | 0001193125-25-100455 |
| 2025-03-31 | 20:23 ET | [10-K](/filings/0000950170-25-047775.md) | Annual report, period 2024-12-31 | 0000950170-25-047775 |
| 2025-03-31 | 20:17 ET | [8-K](/filings/0000950170-25-047755.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-047755 |
| 2025-03-27 | 20:35 ET | [8-K](/filings/0001193125-25-065564.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-065564 |
| 2025-02-28 | 21:05 ET | [8-K](/filings/0001193125-25-042468.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-042468 |
| 2025-01-15 | 21:57 ET | [8-K](/filings/0001193125-25-007107.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-007107 |
| 2024-12-20 | 20:06 ET | [8-K](/filings/0001193125-24-283008.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-283008 |
| 2024-10-31 | 10:07 ET | [8-K](/filings/0001193125-24-248083.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248083 |
| 2024-10-29 | 21:19 ET | [10-Q](/filings/0000950170-24-118366.md) | Quarterly report, period 2024-09-30 | 0000950170-24-118366 |
| 2024-10-29 | 21:06 ET | [8-K](/filings/0000950170-24-118344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118344 |
| 2024-09-27 | 20:02 ET | [8-K](/filings/0001193125-24-227940.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-227940 |
| 2024-07-31 | 20:14 ET | [10-Q](/filings/0000950170-24-088584.md) | Quarterly report, period 2024-06-30 | 0000950170-24-088584 |
| 2024-07-31 | 20:13 ET | [8-K](/filings/0000950170-24-088581.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-088581 |
| 2024-06-12 | 21:08 ET | [8-K](/filings/0001193125-24-160033.md) | 5.07 Shareholder vote results | 0001193125-24-160033 |
| 2024-06-07 | 20:02 ET | [8-K](/filings/0001193125-24-157310.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-157310 |
| 2024-05-02 | 20:12 ET | [8-K](/filings/0000950170-24-052121.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-052121 |
| 2024-05-02 | 20:05 ET | [10-Q](/filings/0000950170-24-052082.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052082 |
| 2024-04-26 | 20:01 ET | [DEF 14A](/filings/0001193125-24-117942.md) | Proxy statement, period 2024-06-12 | 0001193125-24-117942 |
| 2024-04-01 | 20:06 ET | [8-K](/filings/0001193125-24-083352.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-083352 |
| 2024-04-01 | 20:05 ET | [8-K](/filings/0000950170-24-039304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-039304 |
| 2024-03-28 | 20:05 ET | [10-K](/filings/0000950170-24-038026.md) | Annual report, period 2023-12-31 | 0000950170-24-038026 |

Page 1 of 3. [Older](/companies/bmea/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.